Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire

BACKGROUND: Although COVID-19 has spread in Côte d’Ivoire, there is no report that summarizes the comorbidities of COVID-19 death cases. OBJECTIVE: To verify the types and prevalence of commodities associated with recorded COVID-19 deaths compared with the general adult population in Côte d’Ivoire....

Descripción completa

Detalles Bibliográficos
Autores principales: Usui, Rui, Kanamori, Shogo, Aomori, Maki, Watabe, Setsuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2022
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667576/
https://www.ncbi.nlm.nih.gov/pubmed/36405523
http://dx.doi.org/10.4081/jphia.2022.1748
Descripción
Sumario:BACKGROUND: Although COVID-19 has spread in Côte d’Ivoire, there is no report that summarizes the comorbidities of COVID-19 death cases. OBJECTIVE: To verify the types and prevalence of commodities associated with recorded COVID-19 deaths compared with the general adult population in Côte d’Ivoire. METHODS: Data on the comorbidities of COVID-19 deaths and the country’s disease structure were collected from official government reports and WHO’s reports. RESULTS: Among 67 patients studied, the biggest age group was 60-69 years old with 23 people (34%). Fifty-four patients (81%) had non-communicable diseases (NCDs) as comorbidities. The prevalence ratio between COVID-19 deaths and general adult population was 8.96 [95% Confidence Interval: 6.86-11.68] for diabetes, 1.74 [1.27-2.37] for hypertension, and 2.16 [1.32-3.51] for obesity. CONCLUSIONS: To reduce the risk of death from COVID-19 in Côte d’Ivoire, focused infection prevention measures for elderly and diabetic patients are needed.

Ejemplares similares